Kyntra Bio (KYNB) Assets (2014 - 2026)
Kyntra Bio (KYNB) posted Assets of $109.6 million for Q1 2026, down 8.33% sequentially from $119.6 million in Q4 2025, and down 33.64% YoY from $165.2 million in Q1 2025.
Kyntra Bio (KYNB) Assets (2014 - 2026) Analysis & Trends
Kyntra Bio has reported Assets for 13 years, with the latest figure at $109.6 million in Q1 2026.
- Quarterly Assets fell 33.64% year-over-year to $109.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $109.6 million (down 33.64% YoY) and the FY2025 annual result came in at $119.6 million, down 44.25% from the prior year.
- Assets retreated to $109.6 million in Q1 2026 per KYNB's latest filing, from $119.6 million in the prior quarter.
- Over five years, Assets peaked at $745.9 million in Q1 2022 and troughed at $109.6 million in Q1 2026.
- A 5-year average of $378.6 million and a median of $365.9 million in 2024 frame the typical range for Assets.
- The sharpest annual moves came in 2022 and 2025: Assets declined 5.25% in 2022, then tumbled 54.84% in 2025.
- Over 5 years, Assets stood at $610.1 million in 2022, then slumped by 30.58% to $423.5 million in 2023, then slumped by 49.35% to $214.5 million in 2024, then plunged by 44.25% to $119.6 million in 2025, then declined by 8.33% to $109.6 million in 2026.
- According to Business Quant data, Assets over the past three periods registered $109.6 million, $119.6 million, and $137.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 5.56 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 2.10 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 19.82 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 25.60 Bn |
| 10 | Kyntra Bio | 29.83 Mn | 29.83 Mn | 1.47 Mn | 101.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 101.08 Mn |
| Mar 31, 2026 | 109.63 Mn |
| Dec 31, 2025 | 119.59 Mn |
| Sep 30, 2025 | 137.01 Mn |
| Jun 30, 2025 | 178.06 Mn |
| Mar 31, 2025 | 165.21 Mn |
| Dec 31, 2024 | 214.53 Mn |
| Sep 30, 2024 | 264.42 Mn |
| Jun 30, 2024 | 293.20 Mn |
| Mar 31, 2024 | 365.87 Mn |
| Dec 31, 2023 | 423.53 Mn |
| Sep 30, 2023 | 460.43 Mn |
| Jun 30, 2023 | 515.13 Mn |
| Mar 31, 2023 | 538.54 Mn |
| Dec 31, 2022 | 610.09 Mn |
| Sep 30, 2022 | 608.84 Mn |
| Jun 30, 2022 | 686.79 Mn |
| Mar 31, 2022 | 745.93 Mn |
| Dec 31, 2021 | 773.82 Mn |
| Sep 30, 2021 | 850.51 Mn |